Intermediate monocytes, a type of immune cell, may contribute to the development and progression of sarcoidosis through the production of TARC — a molecule that attracts other specific immune cells linked to inflammation, according to a small study. These findings point to intermediate monocytes and TARC as potential treatment targets…

A new study suggests that sarcoidosis patients have different expression levels of certain RNA-binding proteins (RBPs) compared to healthy individuals, and that this difference is associated with the development of the disease. The study, “Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis,” was published in the journal…

A new study investigating the frequency and characteristics of sarcoid arthropathy, in which sarcoidosis is accompanied by joint disease, revealed that a majority of patients with sarcoidosis also have sarcoid arthritis. The study “The clinical characteristics of sarcoid arthropathy based on a prospective cohort study” was published in the…

Dearly beloved, Earlier this month, my husband and I attended our niece’s wedding. Later this month, we’ll renew our vows to celebrate our 25th wedding anniversary. It’s no surprise that in between the two events, I’ve been reflecting on love, marriage, and what we mean when we say “I do.”…

It is important to perform a lung biopsy when a change in chest X-ray is seen during pulmonary sarcoidosis monitoring, according to research conducted by Japanese scientists. This way, the rare possibility of complication with multicentric Castleman’s disease (MCD) can be ruled out or in the rare case it is diagnosed, appropriate treatment can be given to the patient.

“What’s in a name? That which we call a rose/ By any other word would smell as sweet.” — Juliet in William Shakespeare’s “Romeo and Juliet” We’ve all heard those words before. Even those who slept through English lit class are familiar with one of the most famous lines from…

The lungs are affected in nearly everyone diagnosed with sarcoidosis in the Netherlands, but most patients in the country don’t have disease severe enough to warrant systemic immune-suppressing treatments at the time of diagnosis. That’s according to the findings of a new study, “Organ involvement in…

Corticosteroids, a type of anti-inflammatory medication, is the most-prescribed treatment for people with sarcoidosis, a study in a U.S. population shows. Also, the study found, a small percentage of these patients are receiving biological therapies (those using compounds derived from living organisms), despite not being approved in…

Sarcoidosis patients can be divided into women over age 40 with skin and eye lesions, and men under 40 with lung involvement, according to a large survey conducted in Japan. The study, titled “Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan,”…